Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» atopic dermatitis
atopic dermatitis
Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis
Pharmaceutical Business Review
Wed, 12/11/19 - 10:33 am
Demira
atopic dermatitis
FDA
fast track
Dupixent's already a blockbuster, but there's much more to come: Sanofi exec
Fierce Pharma
Fri, 11/1/19 - 10:24 am
Sanofi
Dupixent
atopic dermatitis
Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
MorphoSys
Galapagos
Novartis
MOR106
atopic dermatitis
Dupixent
Sanofi
RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193
Pharmaceutical Business Review
Thu, 10/24/19 - 10:13 am
RAPT Therapeutics
RPT193
allergies
atopic dermatitis
clinical trials
Pfizer posts detailed phase 3 data on its Dupixent rival
Fierce Biotech
Sat, 10/12/19 - 12:30 pm
Pfizer
clinical trials
atopic dermatitis
abrocitinib
Dupixent
Sanofi
Regeneron
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pharmaceutical Business Review
Thu, 05/16/19 - 10:55 am
Pfizer
clinical trials
PF-04965842
atopic dermatitis
Why Dermira Stock Jumped Again Today
Motley Fool
Tue, 03/19/19 - 08:19 pm
Demira
lebrikizumab
atopic dermatitis
Microbiome Report for Week Ending 3/9/19
CP Wire
Fri, 03/15/19 - 10:38 am
microbiome
Synlogic
AOBiome
AbbVie
Infant Bacterial Therapeutics
IBD
atopic dermatitis
FDA approves Dupixent for atopic dermatitis in adolescents
BioCentury
Mon, 03/11/19 - 10:15 pm
Dupixent
Regeneron
Sanofi
FDA
atopic dermatitis
Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials
BioSpace
Mon, 02/4/19 - 11:49 am
Eli Lilly
Incyte
olumiant
atopic dermatitis
clinical trials
Microbiome Report for Week Ending 12/1/18
CP Wire
Sat, 12/8/18 - 02:42 pm
microbiome
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Microbiome Report for Week Ending 12/1/18
Mon, 12/10/18 - 09:06 am
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Going gangbusters in atopic dermatitis, the FDA hands Sanofi and Regeneron a fresh coup for their mega-blockbuster star Dupixent
Endpoints
Tue, 11/6/18 - 09:48 am
Sanofi
Regeneron
Dupixent
atopic dermatitis
Sanofi unveils eczema drug data, as regulators mull label expansion
Pharmaforum
Mon, 09/17/18 - 11:16 am
Sanofi
Dupixent
dupilumab
eczema
atopic dermatitis
After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale
Endpoints
Mon, 09/17/18 - 09:48 am
Realm Therapeutics
atopic dermatitis
clinical trials
layoffs
Realm Craters As Another Phase II Trial Fails to Reach Endpoints
BioSpace
Tue, 08/14/18 - 06:42 pm
Realm Therapeutics
atopic dermatitis
clinical trials
PR022
Novartis to Pay as Much as $1 Billion for Rights to Skin Drug
Yahoo/Bloomberg
Thu, 07/19/18 - 09:53 am
Novartis
Galapagos
MorphoSys
MOR106
atopic dermatitis
Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug
Fierce Biotech
Thu, 07/12/18 - 06:17 pm
GSK
Dermavant
Roivant
CSO
tapinarof
psoriasis
atopic dermatitis
Sanofi's Dupixent scores NICE recommendation after price cut
Fierce Pharma
Fri, 06/22/18 - 12:06 pm
Sanofi
NICE
atopic dermatitis
Dupixent
Great data! Huge potential! (Too bad it failed the primary endpoint)
Endpoints
Thu, 09/14/17 - 06:59 pm
Vanda Pharmaceuticals
tradipitant
atopic dermatitis
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »